1 Acyl-CoA/protein interactions are required for many functions essential to life including membrane synthesis, 2 oxidative metabolism, and macromolecular acetylation. However, despite their importance, the global scope 3 and selectivity of these protein-metabolite interactions remains undefined. Here we describe the development 4 of CATNIP (CoA/AcetylTraNsferase Interaction Profiling), a chemoproteomic platform for the high-throughput 5 analysis of acyl-CoA/protein interactions in endogenous proteomes. First, we apply CATNIP to identify acetyl-6 CoA-binding proteins through unbiased clustering of competitive dose-response data. Next, we use this 7 method to profile diverse protein-CoA metabolite interactions, identifying biological processes susceptible to 8 altered acetyl-CoA levels. Finally, we apply systems-level analyses to assess the features of novel protein 9 networks that may interact with acyl-CoAs, and demonstrate a strategy for high-confidence proteomic 10 annotation of acetyl-CoA binding proteins. Overall our studies illustrate the power of integrating 11 chemoproteomics and systems biology, and provide a resource for understanding the roles of acyl-CoA 12 metabolites in biology and disease. 13 14 15
). The circle size reflects the number of proteins matching a given term. Functional enrichment was performed with the tool DAVID (https://david.ncifcrf.gov) by using GO and Swiss-Prot Protein Information Resource terms. clusters 1-3 at this concentration. For palmitoyl-CoA a lower concentration was used (3 μM) in order to ensure 23 solubility and reflect the limited free (non-protein/membrane bound) quantities of LCFA-CoA likely to be present 24 in cells.
26
As an initial rough measure of acyl-CoA selectivity, we performed a global analysis of proteins displaying robust 27 interaction (>2-fold decreased capture) with competitors. Evaluating 1757 proteins quantified in Lys-CoA 28 enrichments, we found that 1566 (89%) were >2-fold competed by at least one CoA/acyl-CoA metabolite (1-6, 29 Fig. 3b , Table S3 ). In general the majority of proteins found to interact with acetyl-CoA (1) also displayed 30 competition by 2-6, suggestive of ligand-binding promiscuity amongst CoA-binding proteins. Examining 31 physiochemically distinct ligands 3-6, a handful of selective interactions were observed for each acyl-CoA ( Fig.   32 3c). Notably, butyryl-CoA (3) showed substantial overlap with protein interactors of 4-6. This may be suggestive 33 of its metabolic stability in lysates, or ability to make high affinity interactions with many classes of CoA-binding 34 proteins at the concentration applied. To compare the magnitude of protein-ligand interactions, we plotted the phosphorylation of pantothentate (vitamin B5) to phosphopantothenate, which constitutes a key step in CoA 23 biosynthesis. Previous biochemical studies have found PANK1 to be allosterically inhibited by acetyl-CoA but 24 not CoA, while PANK2 is strongly inhibited by both ligands (Rock et al., 2002; Zhang et al., 2006) . We found 25 acetyl-CoA interacted more strongly with each enzyme, but did not observe substantial disparity between CoA 26 binding to the two enzyme isoforms. This may reflect differential binding of metabolites to these enzymes in 27 the complex proteomic milieu compared to biochemical assays or, alternatively, a limitation of our method, 28 which uses a single concentration of ligand that may saturate both selective and non-selective interactions.
29
Overall, these studies validate the ability of chemoproteomics to study acyl-CoA/protein interactions and
31
Evaluating the dynamic activity of acetyltransferases in response to metabolic perturbation 32 Coenzyme A (2) is one of the most abundant metabolites in cells. In addition to functioning as an obligate 33 precursor for acyl-CoA biosynthesis, CoA can also serve as a potent feedback inhibitor of members of the AT 34 superfamily. Previously, we used quantitative immunoblotting of chemoproteomic capture experiments to extend this comparison proteome-wide. Capture experiments were performed in the presence of escalating 1 doses of CoA (3, 30, 300 μM), transformed, and clustered using an identical pipeline as in our acetyl-CoA 2 binding experiments above (Table S5 ). Two clusters (3 and 8) exhibited readily interpretable dose-dependent 3 competition profiles, with several additional clusters (1, 2, and 5) displaying hypersensitivity at low 4 concentrations (3 μM) of CoA ( Fig. S4a-b ). Dose-dependent cluster 3 contained KAT2A, CREBBP, and 
12
ACLY, NAT6, and NAT10 ( Fig. 4a ).
13
The unusually strong CoA interaction 
37
Figure 4. Applying CATNIP to profile the susceptibility of ATs to metabolic feedback inhibition. (a) Exemplary competitive dose-response profiles of proteins that interact strongly with CoA and acetyl-CoA. (b) Exemplary competitive dose-response profiles of proteins that interact moderately with CoA and strongly with acetyl-CoA. (c) Scheme for isotopic tracing experiments designed to determine the metabolic source of the acetate group in ac4C. Heavy (U-13 C) glucose or acetate were applied in separate metabolic labeling experiments. Incorporation into ac4C was assessed by digest of total RNA to constituent nucleotides followed by mass isotopomer analysis. (d) Metabolic tracing reveals the major source of ac4C's N4-acetyl group is glucose-derived acetyl-CoA. (e) Disruption of ACLY-dependent glucose-derived acetyl-CoA production reduces levels of ac4C in poly(A)enriched, but not total RNA, fraction. Values represent ≥ 3 replicates, analyzed by two-tailed student's t-test (ns = not significant, *P<0.05, **P<0.01, ***P<0.001).
1
To explore the metabolic inhibition of NAT10 in greater detail, we determined the metabolic source of the 2 acetate group post-transcriptionally introduced into ac4C in proliferating cancer cell lines ( Fig. 4c ). Treatment 3 of cells with isotopically-labeled acetyl-CoA precursors, followed by RNA digest and analysis by LC-MS/MS, 4 revealed that the majority of NAT10-dependent cytidine acetylation stems from glucose-derived acetyl-CoA 5 ( Fig. 4d ). Since the production of glucose-derived acetyl-CoA in human cells is highly dependent on ACLY 28 (38.1%) passed these cut-offs (Table S6) , including the majority of annotated ATs that were enriched by Lys-29 CoA (Fig. 5b ). Acetyltransferases not identified were mostly found to be poorly expressed by RNA Seq ( associated with distinct biological processes, we further analyzed these proteins using Topological Data 33 Analysis (TDA) (Lum et al., 2013) . TDA functions as a geometric approach that can be used to identify shared properties of complex multidimensional datasets that may not be apparent by other methods, and has previously been used to detect biologically-relevant modules in protein complexes from immunoprecipitation CoA biosynthesis were clearly differentiated as the most highly enriched biological process (Fig. S5d ). To 23 further differentiate direct and indirect CoA interactions, we assessed these 45 proteins for sites of high 24 stoichiometry acetylation. Our reasoning was that this criteria may further enrich our analysis for proteins that 28 stoichiometry, Fig. 5d ). Five of these proteins were Uniprot annotated CoA binders (ACLY, CREBBP, HADH,
29
NAT10, NAA10), while one was a member of an AT complex (NAA15). These analyses suggest a multi-30 pronged approach assessing i) statistically significant multi-ligand competition, ii) dose-response clustering,
31
and iii) acetylation stoichiometry may prove most useful for annotation of the CoA-binding proteome, with the 32 caveat that additional stringency will also lead to filtering of some 'true' positives. These findings also imply the 1 acyl-CoA precursors (Kulkarni et al., 2017) . This led us to hypothesize that if an enzyme 1) binds a malonylwhich these PTMs could be correlated with proximity to an acyl-CoA binding site. However, this approach is 23 far from predictive and, even in our curated dataset of high confidence acyl-CoA-binding proteins, found many 24 sites of malonylation mapping far from the annotated active site (Fig. 5e, Fig. S5f ) (Colak et al., 2015) . Although 25 additional studies are needed, our data suggests for many non-enzymatic acylations factors independent of 26 acyl-CoA binding affinity such as lysine nucleophilicity, surface accessibility, and exposure to high local
27
concentrations of electrophilic CoAs may be important determinants for covalent modification.
29
Finally, it is important to note some limitations of our current method, as well as steps that may be taken to 30 optimize it for future applications. To facilitate the development of CATNIP, our initial study employed ion trap 31 mass spectrometers for protein identification. For future experiments, we propose using higher resolution to degree of competition observed when proteomes were pre-incubated with CoA metabolites 1-6. All ligands were 5 assessed at 30 μM besides 1-2, which were assessed at both 3 and 30 μM, and 6 whose competition assessed only at 3 6 μM. In cases where competition was observed at multiple concentrations, the larger log-transformed fold-change 7 value was used for graphical depiction. 
22
Bioinformatic analyses of CATNIP data and correlation with literature datasets
23
A list of annotated CoA-binders was defined by searching the Uniprot database using query terms related 24 to this function including "CoA binding," "CoA," "Coenzyme A," "Acetyltransferase" "HAT," "NAT," "NAA," 25 "GNAT." A similar analysis was performed to annotate AT interactors, using query terms including "HAT 26 complex," "KAT complex," "NAA complex," "NAT complex," and "acetyltransferase complex." Results were 27 then manually curated with irrelevant proteins and duplicates removed, resulting in the term list provided in 28   Table S2 . Correlation of CATNIP enrichment to HeLa cell gene expression and protein abundance ( Fig. S1 29 d-i) was performed using literature RNA-Seq and deep proteomic datasets (Nagaraj et al., 2011) . Venn 30 diagrams comparing overlap between proteins competed 2-fold by acetyl-CoA and all other ligands ( Fig.   31 3b), or metabolic acyl-CoAs 3-6 ( Fig. 3c) 
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Overexpression, non-enzymatic malonylation, and immunoprecipitation of NAT10
20
HEK-293T cells were plated in 10 cm dishes (2.5 x106 cells/dish in 10 ml DMEM media) and allowed to 21 adhere and grow for 24 h. 3xFLAG-tagged NAT10 was overexpressed using FuGENE® 6 transfection reagent (Promega #E2691) according to the manufacturer's instructions. Overexpression was carried out 23 by incubating the cells for 24 h at 37°C under 5% CO2 atmosphere, after which time the cells were 24 harvested, and lysed in potassium phosphate buffer, pH 8, sonicated using a 100 W QSonica XL2000 25 sonicator (3 × 1 s pulse, amplitude 1, 60 s resting on ice between pulses), and quantified using the Qubit
26
Broad Sensitivity Protein Kit (Thermo Fisher # Q33211). Lysates were incubated with 0 or 0.25 mM malonyl-
27
CoA for six hours at 37°C. Anti-FLAG pulldown was performed using FLAG immunoprecipitation kit (Sigma
28
-FLAGIPT1-1KT) according to the manufacturer's instruction. 450ug of lysate was incubated with the anti-
29
FLAG resin over night at 4°C. Eluted protein was ran on SDS-PAGE and immunoblotted against anti-FLAG-30 tag and anti-Malonyl-Lysine antibodies. For immunoblotting, SDS-PAGE gels were transferred to module in an acetyltransferase that modifies a specific tRNA anticodon. EMBO J 28, 1362-1373.
23
Colak, G., Pougovkina, O., Dai, L., Tan, M., Te Brinke, H., Huang, H., Cheng, Z., Park, J., Wan, X., Liu, X., 
